Clinical trial
RDS MultiSense® SpO2 Validation Study
NCT05359328 is registered in ClinicalTrials.gov with Rhythm Diagnostic Systems as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RDS MultiSense® SpO2 Validation Study
- Lead sponsor
- Rhythm Diagnostic Systems
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 26, 2022
- Completion date
- April 29, 2022
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.